Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

2.6K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.6K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

801
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
801
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

577
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
577

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the tumor: recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer.

Biomedical physics & engineering express·2026
Same author

Electron Affinity of the Carbon Dimer from Threshold Photodetachment Spectroscopy.

Physical review letters·2026
Same author

Comparison of [<sup>111</sup>In]octreotide Scintigraphy and [<sup>68</sup>Ga]DOTATOC PET in Gastroenteropancreatic Neuroendocrine Tumors: Concordance of Krenning Scores and Implications for Peptide Receptor Radionuclide Therapy Eligibility.

Neuroendocrinology·2026
Same author

Comprehensive framework for evaluation of deep neural networks in detection and quantification of lymphoma from PET/CT images: Clinical insights, pitfalls, and observer agreement analyses.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

A fully implantable intraspinal microstimulation device for early preclinical evaluation of feasibility, stability, and functionality.

Scientific reports·2026
Same author

First-in-Human Evaluation of [<sup>68</sup>Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Related Experiment Video

Updated: Mar 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Dyslipidemia in Pregnancy.

Robert Wild1, Elizabeth A Weedin1, Don Wilson2

  • 1Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, 1100 N Lindsay Ave, Oklahoma City, OK 73104, USA.

Endocrinology and Metabolism Clinics of North America
|February 20, 2016
PubMed
Summary

Poorly controlled cholesterol and triglycerides in pregnancy can harm maternal and fetal vascular health, potentially leading to long-term cardiometabolic risks for future generations.

Keywords:
DyslipidemiaFetal metabolismHyperlipidemiaMetabolic syndromePregnancy

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

536
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

536
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.1K

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Metabolic Disorders

Background:

  • Pregnancy involves significant metabolic changes, including lipid metabolism.
  • Altered lipid profiles during pregnancy are increasingly linked to adverse health outcomes.
  • Emerging evidence suggests a connection between maternal lipid disorders and long-term cardiometabolic health.

Purpose of the Study:

  • To review current understanding of maternal lipid metabolism during pregnancy.
  • To highlight the association between dyslipidemia and cardiometabolic dysfunction.
  • To discuss the implications for maternal, fetal, and generational cardiovascular health.

Main Methods:

  • Literature review of recent studies on pregnancy dyslipidemia.
  • Analysis of data linking maternal lipid profiles to cardiometabolic outcomes.
  • Synthesis of information on fetal and long-term vascular consequences.

Main Results:

  • Poorly controlled cholesterol and triglycerides in pregnancy are associated with cardiometabolic dysfunction.
  • These lipid abnormalities have detrimental fetal and maternal vascular consequences.
  • Pregnancy dyslipidemia may contribute to long-term cardiovascular risk across generations.

Conclusions:

  • Recognition of disordered maternal lipid metabolism is crucial.
  • Early identification and management can mitigate long-term atherosclerotic burden.
  • This understanding impacts maternal and child vascular health and future cardiovascular risk.